Literature DB >> 25866182

Annexin-A1 controls an ERK-RhoA-NFκB activation loop in breast cancer cells.

Pradeep Bist1, Qian Hui Phua1, Shinla Shu1, Yuan Yi1, Durkeshwari Anbalagan1, Lay Hoon Lee1, Gautam Sethi2, Boon Chuan Low3, Lina H K Lim4.   

Abstract

Wound healing is critical for normal development and pathological processes including cancer cell metastasis. MAPK, Rho-GTPases and NFκB are important regulators of wound healing, but mechanisms for their integration are incompletely understood. Annexin-A1 (ANXA1) is upregulated in invasive breast cancer cells resulting in constitutive activation of NFκB. We show here that silencing ANXA1 increases the formation of stress fibers and focal adhesions, which may inhibit wound healing. ANXA1 regulated wound healing is dependent on the activation of ERK1/2. ANXA1 increases the activation of RhoA, which is dependent on ERK activation. Furthermore, active RhoA is important in NF-κB activation, where constitutively active RhoA potentiates NFκB activation, while dominant negative RhoA inhibits NFκB activation in response to CXCL12 stimulation and active MEKK plasmids. These findings establish a central role for ANXA1 in the cell migration through the activation of NFκB, ERK1/2 and RhoA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Annexin-1 (ANXA1); ERK; Metastasis; Nuclear factor-kappa B (NF-κB); RhoA; Stress fibers

Mesh:

Substances:

Year:  2015        PMID: 25866182     DOI: 10.1016/j.bbrc.2015.03.166

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Annexin A1 in inflammation and breast cancer: a new axis in the tumor microenvironment.

Authors:  Leonardo A Moraes; Patrick B Ampomah; Lina H K Lim
Journal:  Cell Adh Migr       Date:  2018-08-19       Impact factor: 3.405

2.  ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.

Authors:  Yi Yuan; Durkeshwari Anbalagan; Lay Hoon Lee; Ramar Perumal Samy; Muthu K Shanmugam; Alan Prem Kumar; Gautam Sethi; Peter E Lobie; Lina H K Lim
Journal:  Oncotarget       Date:  2016-05-10

3.  AECHL-1 targets breast cancer progression via inhibition of metastasis, prevention of EMT and suppression of Cancer Stem Cell characteristics.

Authors:  Aparajita Dasgupta; Mithila A Sawant; Gayatri Kavishwar; Manish Lavhale; Sandhya Sitasawad
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

4.  Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway.

Authors:  Mohammed-Amine El Azreq; Maleck Kadiri; Marc Boisvert; Nathalie Pagé; Philippe A Tessier; Fawzi Aoudjit
Journal:  Oncotarget       Date:  2016-07-19

5.  Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment.

Authors:  Leonardo A Moraes; Shreya Kar; Sok Lin Foo; Tong Gu; Yi Qian Toh; Patrick B Ampomah; Karishma Sachaphibulkij; Gracemary Yap; Olga Zharkova; Hakim M Lukman; Anna-Marie Fairhurst; Alan Prem Kumar; Lina H K Lim
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

6.  Ac2-26 Induces IKKβ Degradation Through Chaperone-Mediated Autophagy Via HSPB1 in NCM-Treated Microglia.

Authors:  Lu Liu; Dandan An; Junying Xu; Bin Shao; Xing Li; Jing Shi
Journal:  Front Mol Neurosci       Date:  2018-03-15       Impact factor: 5.639

7.  The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.

Authors:  Cheng-Dong Qin; De-Ning Ma; Shi-Zhe Zhang; Ning Zhang; Zheng-Gang Ren; Xiao-Dong Zhu; Qing-An Jia; Zong-Tao Chai; Cheng-Hao Wang; Hui-Chuan Sun; Zhao-You Tang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

8.  Annexin A1/Formyl Peptide Receptor Pathway Controls Uterine Receptivity to the Blastocyst.

Authors:  Cristina B Hebeda; Silvana Sandri; Cláudia M Benis; Marina de Paula-Silva; Rodrigo A Loiola; Chris Reutelingsperger; Mauro Perretti; Sandra H P Farsky
Journal:  Cells       Date:  2020-05-11       Impact factor: 6.600

9.  Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo.

Authors:  Haijie Yu; Liye Shi; Guoxian Qi; Shijie Zhao; Yuan Gao; Yuzhe Li
Journal:  Front Pharmacol       Date:  2016-06-01       Impact factor: 5.810

10.  Conditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB.

Authors:  Radia Forteza; Yolanda Figueroa; Anastasia Mashukova; Vipin Dulam; Pedro J Salas
Journal:  Mol Biol Cell       Date:  2016-05-25       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.